<DOC>
	<DOCNO>NCT00452985</DOCNO>
	<brief_summary>Primary objective : To assess response rate . To record clinical improvement relation stage histopathological grading . Secondary objective : To determine progression free survival . To find overall survival . To evaluate safety study regimen .</brief_summary>
	<brief_title>Docetaxel Carboplatin First-line Chemotherapy Early Stage Well Advanced Metastatic Ovarian Cancer</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Performance status Karnofsky index ≥ 60 % . Early stage well advanced/metastatic ovarian cancer prove abdominal ultrasonography , chest xray , Computerized axial tomography scan . Histologically : epithelial/germ cell Haematology : absolute neutrophil count : ≥2X10^9/L ; Platelet : ≥150X10^9/L ; Haemoglobin : ≥ 10g/dL Liver function : total bilirubin : ≤1X UNL ( upper normal limit ) ; Aspartate transaminase &amp; Alanine aminotransferase : ≤2.5 x UNL ; Alkaline phosphatase : ≤2.5 UNL Renal function : Creatinine : ≤130 µmol/L ; If creatinine &gt; 130 µmol/L , 24 hour creatinine clearance &gt; 60 ml/min . Symptomatic peripheral neuropathy &gt; grade 1 National Cancer Institute Common Toxicity Criteria scale Uncontrolled diabetes mellitus uncontrolled hypertension Pregnant , lactate patient ( patient childbearing potential must use adequate contraception ) . Active infection serious underlie medical condition compatible program entry eg . congestive heart failure , previous myocardial infarction within 6 month prior treatment . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>